EUVIMEDEUVIMED entdecken
Crossref

Atypical cystic hypersecretory lesions of the breast commonly harbour TP53 alterations

Baris Boyraz, Dennis C Sgroi, A John Iafrate, Melinda F Lerwill

Histopathology · 2023

DOI: 10.1111/his.15056 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Histopathology, 2023. Verfasst von Baris Boyraz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: Carcinoma, Carcinoma in Situ, Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Gefördert von: Vickery-Colvin Intradepartmental Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Cystic hypersecretory lesions are rare and include atypical cystic hypersecretory hyperplasia (A‐CHH) and cystic hypersecretory carcinoma in situ (CHC‐IS). Despite detailed morphological descriptions, little is known about the genetic landscape of these lesions. Methods and results We identified four A‐CHH and three CHC‐IS from 2010 to 2022. Patients ranged from 39 to 65 (median 49) years. All lesions showed characteristic cystically dilated ducts with colloid‐like secretions lined by enlarged cells with hyperchromatic nuclei and at least moderate cytological atypia. CHC‐IS was remarkable for a greater degree of intraductal proliferation, typically with a micropapillary pattern. Four patients had concurrent ipsilateral invasive carcinoma. Next‐generation sequencing (104 cancer‐associated genes) was successful in four, showing variants in TP53 (3), KEAP1 (1) and MDM2 (1). p53 immunohistochemistry was concordant with molecular results with mutant‐pattern staining in three TP53 ‐mutants and wild‐type in one. In three cases where sequencing failed, one showed mutant p53 staining, one was wild‐type and one had no remaining lesion. The combined molecular and immunohistochemical results demonstrated p53 alterations in one A‐CHH and three CHC‐IS.

Conclusion

Based on this limited cohort, atypical cystic hypersecretory lesions appear to commonly harbour TP53 alterations. To our knowledge, this is the first study to characterise molecular alterations in this rare subset of breast lesions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CarcinomaCarcinoma in SituBreast NeoplasmsHumansFemaleKelch-Like ECH-Associated Protein 1Tumor Suppressor Protein p53NF-E2-Related Factor 2BreastHyperplasia

Stichwörter der Autor:innen

TP53atypical cystic hypersecretory hyperplasiabreastcystic hypersecretory carcinoma in situ

Substanzen

Kelch-Like ECH-Associated Protein 1Tumor Suppressor Protein p53NF-E2-Related Factor 2TP53 protein, human

Autor:innen und Institutionen

  • Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Förderung

  • Vickery-Colvin Intradepartmental Grant

Zitieren

APA

Boyraz, B., Sgroi, D. C., Iafrate, A. J., & Lerwill, M. F. (2023). Atypical cystic hypersecretory lesions of the breast commonly harbour TP53 alterations. Histopathology. https://doi.org/10.1111/his.15056

Vancouver

Boyraz B, Sgroi DC, Iafrate AJ, Lerwill MF. Atypical cystic hypersecretory lesions of the breast commonly harbour TP53 alterations. Histopathology. 2023. doi:10.1111/his.15056

BibTeX
@article{Boyraz2023,
  author = {Boyraz, Baris and Sgroi, Dennis C and Iafrate, A John and Lerwill, Melinda F},
  title = {Atypical cystic hypersecretory lesions of the breast commonly harbour TP53 alterations},
  journal = {Histopathology},
  year = {2023},
  doi = {10.1111/his.15056}
}
Kostenlos starten →